In addition, we noted that BRAF genetic mutations exhibited mutual exclusivity with TP53 mutations in rectal cancer but significantly cooccurred (p < 0.001) with SMAD4 genetic mutations (p = 0.024). The gene discussed is SMAD4; the disease is rectal cancer.